CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,969 | +35.0% | 15,206 | +49.5% | 0.00% | +100.0% |
| Q2 2023 | $331,778 | -7.5% | 10,171 | -0.2% | 0.00% | -50.0% |
| Q1 2023 | $358,551 | -28.1% | 10,189 | -6.3% | 0.00% | -33.3% |
| Q4 2022 | $498,339 | +146.7% | 10,876 | +160.4% | 0.00% | +200.0% |
| Q3 2022 | $202,000 | +32.9% | 4,177 | +7.8% | 0.00% | 0.0% |
| Q2 2022 | $152,000 | +5.6% | 3,873 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | +45.5% | 3,910 | +79.8% | 0.00% | 0.0% |
| Q4 2021 | $99,000 | +28.6% | 2,175 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $77,000 | +83.3% | 2,157 | +2.0% | 0.00% | – |
| Q2 2021 | $42,000 | -16.0% | 2,114 | -0.8% | 0.00% | -100.0% |
| Q1 2021 | $50,000 | +1566.7% | 2,131 | +1422.1% | 0.00% | – |
| Q4 2020 | $3,000 | -66.7% | 140 | -65.0% | 0.00% | – |
| Q3 2020 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,721,888 | $41,198,000 | 4.18% |
| Virtus ETF Advisers LLC | 93,309 | $672,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 105,324 | $758,000 | 0.55% |
| LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $19,065,000 | 0.20% |
| WASATCH ADVISORS LP | 1,761,882 | $12,686,000 | 0.16% |
| PINNACLE ASSOCIATES LTD | 888,415 | $6,397,000 | 0.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 84,690 | $610,000 | 0.08% |
| Birchview Capital, LP | 10,000 | $72,000 | 0.05% |
| Piermont Capital Management Inc. | 16,530 | $119,000 | 0.04% |
| Tekla Capital Management LLC | 137,797 | $992,000 | 0.04% |